60 Degrees Pharmaceuticals Shares Are Trading Higher After the Company Signed Clinical Trial Agreements With Three Planned Trial Sites for the Tafenoquine Babesiosis Study
60度药品股价上涨,公司与三个计划试验地签订了Tafenoquine Babesiosis研究的临床试验协议
60 Degrees Pharmaceuticals Shares Are Trading Higher After the Company Signed Clinical Trial Agreements With Three Planned Trial Sites for the Tafenoquine Babesiosis Study
60度药品股价上涨,公司与三个计划试验地签订了Tafenoquine Babesiosis研究的临床试验协议
使用浏览器的分享功能,分享给你的好友吧